{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:10:40Z","timestamp":1790831440779,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"am","delay-in-days":410,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00c3\u00a9 et de la Recherche M\u00c3\u00a9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002738","name":"Assistance Publique - H\u00c3\u00b4pitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00c3\u00a9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012946","name":"Association Sorbonne Universit\u00c3\u00a9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ando.2019.10.003","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T07:04:29Z","timestamp":1576479869000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Lipodystrophic syndromes: From diagnosis to treatment"],"prefix":"10.1016","volume":"81","author":[{"given":"Camille","family":"Sollier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Vatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Capel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lascols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Auclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Janmaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"F\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"J\u00e9ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2019.10.003_bib0275","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0280","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/03007995.2018.1533459","article-title":"Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases","volume":"35","author":"Vatier","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ando.2019.10.003_bib0285","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molimm.2019.05.011","article-title":"An overview of lipodystrophy and the role of the complement system","volume":"112","author":"Corvillo","year":"2019","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ando.2019.10.003_bib0290","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11892-018-1076-3","article-title":"Diabetes and HIV","volume":"18","author":"Noubissi","year":"2018","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.ando.2019.10.003_bib0295","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.2337\/diabetes.49.11.1958","article-title":"Lamin A\/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy","volume":"49","author":"Vigouroux","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.ando.2019.10.003_bib0300","doi-asserted-by":"crossref","first-page":"E1410","DOI":"10.1210\/jc.2013-1297","article-title":"Increased skeletal muscle volume in women with familial partial lipodystrophy, Dunnigan variety","volume":"98","author":"Ji","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0305","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1007487","article-title":"Perilipin deficiency and autosomal dominant partial lipodystrophy","volume":"364","author":"Gandotra","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2019.10.003_bib0310","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1210\/jc.2019-00849","article-title":"Diagnostic challenge in PLIN1-associated Familial Partial Lipodystrophy","volume":"104","author":"J\u00e9ru","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0315","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1093\/hmg\/ddv229","article-title":"Homozygous mutations in MFN2 cause multiple symmetric lipomatosis associated with neuropathy","volume":"24","author":"Sawyer","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ando.2019.10.003_bib0320","first-page":"6","article-title":"Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression","author":"Rocha","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.ando.2019.10.003_bib0325","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jacl.2018.07.009","article-title":"MFN2-associated lipomatosis: clinical spectrum and impact on adipose tissue","volume":"12","author":"Capel","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ando.2019.10.003_bib0330","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jc.2002-021506","article-title":"A new clinical condition linked to a novel mutation in lamins A and C with generalised lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy","volume":"88","author":"Caux","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0335","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1210\/jc.2009-0472","article-title":"Atypical progeroid syndrome due to heterozygous missense LMNA mutations","volume":"94","author":"Garg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0340","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1750-1172-8-106","article-title":"Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome","volume":"8","author":"Donadille","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ando.2019.10.003_bib0345","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1172\/JCI81260","article-title":"Additive loss-of-function proteasome subunit mutations in CANDLE\/PRAAS patients promote type I IFN production","volume":"125","author":"Brehm","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2019.10.003_bib0350","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molmet.2018.05.006","article-title":"Surplus fat rapidly increases fat oxidation and insulin resistance in lipodystrophic mice","volume":"13","author":"Girousse","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0355","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI7901","article-title":"Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice","volume":"105","author":"Gavrilova","year":"2000","journal-title":"J Clin Invest"},{"issue":"Pt 2","key":"10.1016\/j.ando.2019.10.003_bib0360","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1042\/bst0290072","article-title":"Regional differences in protein production by human adipose tissue","volume":"29","author":"Arner","year":"2001","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ando.2019.10.003_bib0365","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/dom.12606","article-title":"One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes","volume":"18","author":"Vatier","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0370","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2019.10.003_bib0375","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","article-title":"PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy","volume":"93","author":"Thauvin-Robinet","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ando.2019.10.003_bib0380","doi-asserted-by":"crossref","first-page":"e88766","DOI":"10.1172\/jci.insight.88766","article-title":"Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations","volume":"1","author":"Huang-Doran","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ando.2019.10.003_bib0385","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/dc07-2194","article-title":"Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance","volume":"31","author":"Semple","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2019.10.003_bib0390","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jc.2011-1896","article-title":"Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome","volume":"97","author":"Lungu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0395","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2019.10.003_bib0400","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.metabol.2004.08.021","article-title":"The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients","volume":"54","author":"Musso","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.ando.2019.10.003_bib0405","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000439432","article-title":"Effects of recombinant human leptin (Metreleptin) on nocturnal luteinizing hormone secretion in lipodystrophy patients","volume":"103","author":"Abel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2019.10.003_bib0410","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1210\/jc.2007-2521","article-title":"Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy","volume":"93","author":"Vantyghem","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0415","doi-asserted-by":"crossref","first-page":"e0199052","DOI":"10.1371\/journal.pone.0199052","article-title":"Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy","volume":"13","author":"Lima","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ando.2019.10.003_bib0420","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00256-016-2457-9","article-title":"Bone imaging findings in genetic and acquired lipodystrophic syndromes: an imaging study of 24 cases","volume":"45","author":"Teboul-Cor\u00e9","year":"2016","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.ando.2019.10.003_bib0425","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg.39.10.722","article-title":"Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy","volume":"39","author":"Van Maldergem","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.ando.2019.10.003_bib0430","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jmedgenet-2013-101525","article-title":"A new seipin-associated neurodegenerative syndrome","volume":"50","author":"Guill\u00e9n-Navarro","year":"2013","journal-title":"J Med Genet"},{"key":"10.1016\/j.ando.2019.10.003_bib0435","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalised lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2019.10.003_bib0440","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1042\/BST20110670","article-title":"Clinical and genetic heterogeneity in laminopathies","volume":"39","author":"Bertrand","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ando.2019.10.003_bib0445","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/19491034.2018.1456217","article-title":"Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives","volume":"9","author":"Vigouroux","year":"2018","journal-title":"Nucleus"},{"key":"10.1016\/j.ando.2019.10.003_bib0450","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/jc.2007-0654","article-title":"New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome","volume":"92","author":"Decaudain","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0455","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/hmg\/ddy055","article-title":"The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T\/Brachyury and early vascular differentiation gene networks","volume":"27","author":"Briand","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ando.2019.10.003_bib0460","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.diabet.2018.09.006","article-title":"Cardiometabolic assessment of lamin A\/C gene mutation carriers: a phenotype-genotype correlation","volume":"45","author":"Kwapich","year":"2019","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0465","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2019.10.003_bib0470","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/ATVBAHA.113.301933","article-title":"Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction","volume":"33","author":"Bidault","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ando.2019.10.003_bib0475","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jmedgenet-2016-104437","article-title":"LMNA-associated partial lipodystrophy: anticipation of metabolic complications","volume":"54","author":"J\u00e9ru","year":"2017","journal-title":"J Med Genet"},{"key":"10.1016\/j.ando.2019.10.003_bib0480","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2008-1703","article-title":"Complement abnormalities in acquired lipodystrophy revisited","volume":"94","author":"Savage","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0485","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3389\/fimmu.2018.02142","article-title":"Autoantibodies Against Perilipin 1 as a Cause of Acquired Generalized Lipodystrophy","volume":"9","author":"Corvillo","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ando.2019.10.003_bib0490","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2018-00494","article-title":"Case Report of Acquired Generalized Lipodystrophy Associated With Common Variable Immunodeficiency","volume":"103","author":"Halpern","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0495","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1210\/jc.2015-3722","article-title":"Progressive Generalized Lipodystrophy as a Manifestation of Autoimmune Polyglandular Syndrome Type 1","volume":"101","author":"Sorkina","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0500","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1172\/JCI58414","article-title":"A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans","volume":"121","author":"Kitamura","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2019.10.003_bib0505","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3389\/fimmu.2017.00927","article-title":"CANDLE Syndrome As a Paradigm of Proteasome-Related Autoinflammation","volume":"8","author":"Torrelo","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.ando.2019.10.003_bib0510","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jbspin.2018.11.003","article-title":"New data in causes of autoinflammatory diseases","volume":"86","author":"Kone-Paut","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ando.2019.10.003_bib0515","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2353\/ajpath.2009.080505","article-title":"Adipose tissue sensitivity to radiation exposure","volume":"174","author":"Poglio","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ando.2019.10.003_bib0520","doi-asserted-by":"crossref","DOI":"10.1530\/EC-18-0497","article-title":"Lipodystrophy-like features after total body irradiation among survivors of childhood acute leukemia","author":"Visentin","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2019.10.003_bib0525","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1172\/JCI95476","article-title":"Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy","volume":"128","author":"Brown","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2019.10.003_bib0530","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2014-4491","article-title":"Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin","volume":"100","author":"Diker-Cohen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2019.10.003_bib0535","unstructured":"Recommendations from the Transparency Committee of the French National Authority for Health (HAS) on Metreleptin Therapy: https:\/\/www.has-sante.fr\/portail\/upload\/docs\/evamed\/CT-17322_MYALEPTA_PIC_INS_Avis2_CT17322&17457.pdf. and https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2019-09\/myalepta_summary_ct17457.pdf."},{"key":"10.1016\/j.ando.2019.10.003_bib0540","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13023-019-1141-2","article-title":"Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes","volume":"14","author":"Vatier","year":"2019","journal-title":"Orphanet J Rare Dis"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426619302343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426619302343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:25:11Z","timestamp":1762086311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426619302343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0003426619302343"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2019.10.003","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipodystrophic syndromes: From diagnosis to treatment","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2019.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}